Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension
about
Antibodies in the pathogenesis of hypertensionAngiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyondAlpha1A-adrenergic receptor-directed autoimmunity induces left ventricular damage and diastolic dysfunction in rats.Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanismSodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells.Antibodies to the α1-adrenergic receptor cause vascular impairments in rat brain as demonstrated by magnetic resonance angiographyThe immunological basis of hypertensionAutoimmunity: an underlying factor in the pathogenesis of hypertension.Preventing autoimmunity protects against the development of hypertension and renal injury.Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbitReceptor-activating autoantibodies and disease: preeclampsia and beyond.Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant ratsElevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia.Implications of a vasodilatory human monoclonal autoantibody in postural hypotensionB cells as under-appreciated mediators of non-auto-immune inflammatory disease.Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart functionActivating autoantibodies and cardiovascular disease.The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors.Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.Selectivity of pharmacological tools: implications for use in cell physiology. A review in the theme: Cell signaling: proteins, pathways and mechanisms.The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review.Device-Based Approaches for the Treatment of Arterial Hypertension.Understanding mechanisms of hypertension in systemic lupus erythematosus.Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune DiseaseAssociations of Variants in the CACNA1A and CACNA1C Genes With Longitudinal Blood Pressure Changes and Hypertension Incidence: The GenSalt StudyInflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase.Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats.Agonistic autoantibodies to the α(1) -adrenergic receptor and the β(2) -adrenergic receptor in Alzheimer's and vascular dementia.Immunoadsorption of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients With Mild to Moderate Dementia.National Heart, Lung, and Blood Institute Working Group Report on Salt in Human Health and Sickness: Building on the Current Scientific Evidence.Doxazosin attenuates renal matrix remodeling mediated by anti-α1-adrenergic receptor antibody in a rat model of diabetes mellitus.Autoantibodies targeting AT1 receptor from patients with acute coronary syndrome upregulate proinflammatory cytokines expression in endothelial cells involving NF-κB pathway.Association analysis about HLA-DRB1, -DQB1 polymorphism and auto-antibodies against α(1)-adrenergic receptors in Chinese patients with essential hypertension.Autoantibodies against AT1 and α1-adrenergic receptors predict arterial stiffness progression in normotensive subjects over a 5-year period.Cerebral blood volume estimation by ferumoxytol-enhanced steady-state MRI at 9.4 T reveals microvascular impact of α1 -adrenergic receptor antibodies.Autoantibodies against angiotensin and adrenergic receptors: more than a biomarker?Functional autoantibodies in patients with different forms of dementia.
P2860
Q26828588-057ADCAD-7305-4124-84E5-A9E37CDCB687Q27027039-91D36D31-D7EF-41E7-B406-9A1F2389A6A9Q33535920-DF673164-EFA4-42E8-A8E5-48281439B9FDQ34244290-429EABD2-F8C7-424D-91E8-82C83B816047Q34331407-CED51977-3E86-4ECC-92F1-B6C5F69B422CQ34364148-ECFB1614-F95D-441B-91CB-889349622062Q34683745-16FC1096-5B3E-4586-9176-8F1B9B5673C8Q35116086-B6552359-BAE3-4C4C-BB4B-03B5580F2298Q35159241-D0A6CDDC-BD56-4C39-BD75-FA20E1968E57Q35175458-A672A610-79ED-4C01-8B18-2C47FAD50EF0Q35707881-6FF89E79-435D-4AD3-8271-136E3F7B0808Q36683260-AC1E54B8-5A2B-493D-816A-86CB025EABD1Q36836373-55EBBA5C-CC7D-4B92-B479-289941816E3BQ37234140-2CC88EC4-2711-457E-BA32-ACAC5F106069Q37728724-7A765859-1947-419C-92EA-33EA7DAF0367Q37973384-0CE30B0A-4E02-46F5-941C-29ABD731E919Q38118625-1DC18ADF-9709-4052-9318-2C880BE0ADE6Q38171958-89DE6D2E-B180-454D-8FD3-CBDF3106C16CQ38207936-5722C416-2E12-43B3-B666-99DFB7E63960Q38336214-76B5F444-D738-48FC-A64D-17EE2E98B402Q38652607-17A37BB0-5638-435D-9FCE-0CB120593379Q38722982-3C6F3781-DD8A-44B7-B933-91D0B61EE31FQ38777852-92CFFDDD-C38D-4CB8-A6DB-0D824F2D954BQ38938727-4CE347D5-6634-4E2B-9155-6008A9C57C43Q39083135-6E30FAAB-7E46-4409-BFCA-E1B8B31288A6Q39198610-7BC219A9-ABF9-4922-8742-46C0F22C9175Q39378416-1E2B3F87-C540-462E-89F4-62FCE6AA8DCEQ39409827-ABC1BBE8-4956-4691-96E6-AAB643C5D282Q39837503-2F1116CB-AA7F-4928-8F41-9D1D1C5305A6Q40690970-2EC4470E-DFEF-4A9F-8661-06E961D6FB46Q41672015-499AD7E5-C909-4DB1-A13E-93D49A4523A4Q42652420-5D4FDFF7-F646-4AD8-BB7F-BB3C28AF1705Q42796924-0300018B-2287-44B2-B82E-D4DDFBA8A504Q47447474-8F426D01-E631-4D79-AC18-05C00FA1585BQ48638550-0E0E4C17-D411-40A6-8898-4651CF79ADF1Q50077615-66676456-B19D-43C2-92D1-8335A408F33DQ52807608-76ABB1E9-371A-4601-AED0-9201BDEEDC13
P2860
Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension
description
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique PLoS ONE
@fr
artículu científicu espublizáu en 2008
@ast
scientific journal article
@en
vedecký článok (publikovaný 2008/01/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/01/01)
@nl
wissenschaftlicher Artikel
@de
наукова стаття, опублікована в січні 2008
@uk
name
Potential relevance of alpha(1 ...... ies in refractory hypertension
@ast
Potential relevance of alpha(1 ...... ies in refractory hypertension
@en
Potential relevance of alpha(1 ...... ies in refractory hypertension
@nl
type
label
Potential relevance of alpha(1 ...... ies in refractory hypertension
@ast
Potential relevance of alpha(1 ...... ies in refractory hypertension
@en
Potential relevance of alpha(1 ...... ies in refractory hypertension
@nl
prefLabel
Potential relevance of alpha(1 ...... ies in refractory hypertension
@ast
Potential relevance of alpha(1 ...... ies in refractory hypertension
@en
Potential relevance of alpha(1 ...... ies in refractory hypertension
@nl
P2093
P2860
P50
P1433
P1476
Potential relevance of alpha(1 ...... ies in refractory hypertension
@en
P2093
Carsten Lindschau
Christoph Schroeder
Hannelore Haase
Herbert Schulz
Ingo Morano
Katrin Wenzel
Marion Janczikowski
Norbert Hubner
Peter Karczewski
Rainer Dietz
P2860
P356
10.1371/JOURNAL.PONE.0003742
P407
P577
2008-01-01T00:00:00Z